Ontology highlight
ABSTRACT:
SUBMITTER: Sasaki R
PROVIDER: S-EPMC6323517 | biostudies-literature | 2018 Dec
REPOSITORIES: biostudies-literature
Sasaki Reina R Kanda Tatsuo T Kato Naoya N Yokosuka Osamu O Moriyama Mitsuhiko M
World journal of hepatology 20181201 12
The introduction of a direct-acting antiviral (DAA) for patients with hepatitis C virus (HCV) infection, could lead to higher sustained virologic response (SVR) rates with fewer adverse events, and it could shorten the treatment duration relative to the interferon era. Although most recent clinical studies have demonstrated that the occurrence rates of hepatocellular carcinoma (HCC) are decreased by SVR with both interferon-based and interferon-free-regimens, there are several reports about the ...[more]